Avadel Pharmaceuticals
AVDL
#4800
Rank
ยฃ1.18 B
Marketcap
ยฃ12.34
Share price
1.40%
Change (1 day)
41.45%
Change (1 year)

Revenue for Avadel Pharmaceuticals (AVDL)

Revenue in 2024 (TTM): ยฃ75.34 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ73.63 Million. In 2023 the company made a revenue of ยฃ21.94 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avadel Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ75.34 M243.29%
2023 ยฃ21.94 M
2022 N/A
2021 N/A-100%
2020 ยฃ16.38 M-63.72%
2019 ยฃ45.15 M-44.49%
2018 ยฃ81.35 M-36.53%
2017 ยฃ0.12 B5.27%
2016 ยฃ0.12 B4.9%
2015 ยฃ0.11 B2717.47%
2014 ยฃ4.11 M-69.72%
2013 ยฃ13.6 M-15.75%
2012 ยฃ16.14 M-23.01%
2011 ยฃ20.97 M-12.71%
2010 ยฃ24.02 M-7.68%
2009 ยฃ26.02 M-1.22%
2008 ยฃ26.35 M42.82%
2007 ยฃ18.45 M56.99%
2006 ยฃ11.75 M-14.12%
2005 ยฃ13.68 M-61.79%
2004 ยฃ35.81 M158.33%
2003 ยฃ13.86 M21.07%
2002 ยฃ11.45 M26.87%
2001 ยฃ9.02 M25.6%
2000 ยฃ7.18 M5.16%
1999 ยฃ6.83 M19.34%
1998 ยฃ5.72 M17.59%
1997 ยฃ4.87 M70.18%
1996 ยฃ2.86 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.17 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.55 B 652.89%๐Ÿ‡บ๐Ÿ‡ธ USA